Follow the money trail… DEA granted C-II status to THC to “bad actor company “
DEA finalizing Schedule II status for synthetic THC drug Syndros www.thecannabist.co/2017/11/21/dea-syndros-synthetic-thc-insys-schedule-ii/92862/ The U.S. Drug Enforcement Administration this week…
